FGF23 and type 2 diabetes mellitus: These findings warrant for future studies to examine the predictive value of FGF-23 for cardiovascular morbidity and mortality in patients with type 2 diabetes, as FGF-23 may prove to be a useful biomarker for identifying patients at high risk of adverse cardiovascular outcome.